Brind.

An analyst maintained a Buy rating for Structure Therapeutics Inc. on June 25, 2025.

1 report, 1 independent Updated Jun 25

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

SonG

Keep exploring

The entities involved

SonG
French progamer
- SonG discussed budget with The Hustler. Meanwhile, Will Dean and Simran campaigned regarding external programming, with Dean holding a vice presidency in the VSG Senate.Sun 00:27

Coverage

Newest first; wire copies grouped

Jun 25Insider MonkeyJefferies Reiterates a Buy Rating on Structure Therapeutics (GPCR) With a $79 PT Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the 13 Small Cap Stocks Analysts Are Bullish On. Jefferies analyst